WuXi Biologics has agreed to sell its Dundalk vaccine manufacturing facility to Merck, a move that will enhance asset efficiencies and allow the company to focus on CDMO services at its other global sites.
https://european-biotechnology.com/wp-content/uploads/2025/01/wuxi-biologics-buffer-prep-room.jpg540960Michael Kuhrt/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMichael Kuhrt2025-01-07 17:26:002025-01-08 13:12:50WuXi Biologics Sells Irish Vaccine Site to Merck for $500m
Orbis Medicines secures €90m in Series A funding to accelerate the development of oral macrocycle drugs, leveraging automated chemistry and machine learning.
https://european-biotechnology.com/wp-content/uploads/2024/12/Weihnachten-2024.jpg.webp8531280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-12-23 08:59:292024-12-23 08:59:29Merry Christmas and a Happy New Year
In parallel with the expansion of its collaboration with SK Bioscience Co. Ltd, the French pharmaceutical company Sanofi SA has announced Phase III testing of its licensed pneumococcal conjugate vaccine PCV21.
https://european-biotechnology.com/wp-content/uploads/2024/12/SK-Bioscience-scaled-e1734938427279.jpg9171570Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-12-23 08:47:382024-12-23 08:47:38Sanofi expands collaboration with SK Bioscience
https://european-biotechnology.com/wp-content/uploads/2025/01/EB.com_Darren_Verlenden_CEO-Single_Use_Support.jpg472420Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2024-12-20 15:27:452025-01-29 08:46:16New CEO completes management team
Screening a library of 712 market-approved drugs, German researchers have found that a cough medicine most efficiently reduced incurable lung fibrosis in mice and in vitro.
LAB Automation – The Society for Laboratory Automation and Screening (SLAS) is transforming the global life sciences community by uniting interdisciplinary researchers and technology providers to drive innovation in laboratory automation and research.
Generative AI specialist DeepLife SAS has raises US$10m in a Series A financing led by YZR Capital and Relyens Innovation Santé with participation from Beiersdorf Venture Capital, Prunay Group, and existing investors.
https://european-biotechnology.com/wp-content/uploads/2024/12/deeplife-team.webp470780Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-12-17 09:09:562024-12-18 11:51:12DeepLife raises US$10m in Series A financing
Researchers at Sorbonne Paris have discovered that a membrane protein in adipocytes of obese mice and humans changes the lipid composition of adipose tissue macrophages rendering them more inflammatory and reducing insulin resistance.
WuXi Biologics Sells Irish Vaccine Site to Merck for $500m
Latest NewsWuXi Biologics has agreed to sell its Dundalk vaccine manufacturing facility to Merck, a move that will enhance asset efficiencies and allow the company to focus on CDMO services at its other global sites.
Orbis Medicines secures €90m to advance oral macrocycle drugs
Latest NewsOrbis Medicines secures €90m in Series A funding to accelerate the development of oral macrocycle drugs, leveraging automated chemistry and machine learning.
Merry Christmas and a Happy New Year
Latest NewsThank you for a successful 2024!
Sanofi expands collaboration with SK Bioscience
Latest NewsIn parallel with the expansion of its collaboration with SK Bioscience Co. Ltd, the French pharmaceutical company Sanofi SA has announced Phase III testing of its licensed pneumococcal conjugate vaccine PCV21.
New CEO completes management team
AppointmentsKufstein-based Single Use Support appointed Darren Verlenden as CEO and strengthens leadership team.
Cough medicine reverses fibrosis in animal models
Latest NewsScreening a library of 712 market-approved drugs, German researchers have found that a cough medicine most efficiently reduced incurable lung fibrosis in mice and in vitro.
Revolutionising research
AssociationsLAB Automation – The Society for Laboratory Automation and Screening (SLAS) is transforming the global life sciences community by uniting interdisciplinary researchers and technology providers to drive innovation in laboratory automation and research.
Photys Therapeutics inks deal with Novo Nordisk
Latest NewsNovo Nordiks has licenced Photys Therapeutics PHICS platform to target a single cardiometabolic target. Photys got US$186m upfront.
DeepLife raises US$10m in Series A financing
Latest NewsGenerative AI specialist DeepLife SAS has raises US$10m in a Series A financing led by YZR Capital and Relyens Innovation Santé with participation from Beiersdorf Venture Capital, Prunay Group, and existing investors.
Membrane target triggers inflammation
Background, Latest NewsResearchers at Sorbonne Paris have discovered that a membrane protein in adipocytes of obese mice and humans changes the lipid composition of adipose tissue macrophages rendering them more inflammatory and reducing insulin resistance.